OREXIGEN THERAPEUTICS INC - COM NEW (OREXQ)

CUSIP: 686164302

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM NEW
Total 13F shares
5,869,045
Share change
-475,380
Total reported value
$10,211,000
Put/Call ratio
1579%
Price per share
$1.74
Number of holders
42
Value change
-$2,216,914
Number of buys
20
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 686164302?
CUSIP 686164302 identifies OREXQ - OREXIGEN THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OREXIGEN THERAPEUTICS INC - COM NEW (OREXQ) as of Q4 2016

As of 31 Dec 2016, OREXIGEN THERAPEUTICS INC - COM NEW (OREXQ) was held by 42 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,869,045 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, BVF INC/IL, Foresite Capital Management II, LLC, NEA Management Company, LLC, VANGUARD GROUP INC, CREDIT SUISSE AG/, Foresite Capital Management III, LLC, BlackRock Institutional Trust Company, N.A., Old West Investment Management, LLC, and Rock Springs Capital Management LP. This page lists 42 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.